Tuesday, June 3, 2014 | 9:30 AM - 2:30 PM
Keynote Speaker: Michael Marletta (The Scripps Research Institute)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.
Thursday, July 31, 2014 | 8:00 AM - 5:00 PM
Speakers: C. Thomas Caskey (Baylor College of Medicine, Houston, TX, USA), Jason Chin (University of Cambridge, UK), Gregory A. Petsko (Weill Cornell Medical College, New York, NY, USA), Frank Portugal (The Catholic University of America, Washington, DC, USA), Venki Ramakrishnan (MRC Laboratory of Molecular Biology, Cambridge, UK), Jonathan Weissman (University of California - San Francisco, California, CA, USA), Lei Wang (The Salk Institute for Biological Studies, La Jolla, California, USA), Huanming Yang (BGI, Shenzhen, China)
The identification of the genetic code has offered many opportunities in scientific, medical and biological discovery. This symposium honors Nobel Laureate Marshall Nirenberg and showcases research in a range of therapeutic areas.
Thursday, March 20, 2014 | 6:00 PM - 8:30 PM
Speaker: Sean F. Brady (The Rockefeller University), Steven Edgar (MIT), Justin Nodwell (University of Toronto), Kang Zhou (MIT)
Secondary metabolites or idiolites play many roles in biological systems, including communication, defense and signaling. This symposium takes a systems biology approach to explore their biological effects and potential benefits for human health.
Tuesday, January 28, 2014 | 8:30 AM - 4:30 PM
Speakers: Nahor Haddish-Berhane (Pfizer), Sara Hurvitz (UCLA Medical Center), Omar Kabbarah (Genentech Inc.), Peter D. Senter (Seattle Genetics, Inc.), Dhaval K. Shah (The State University of New York at Buffalo), Stacey S. Shord (Food and Drug Administration), Melissa M. Schutten (Genentech Inc.), and Puja Sapra (Pfizer), Alan Wahl (Ambrx)
Antibody-drug conjugates (ADCs) promise safer, more effective therapies than standard anti-cancer drugs. This symposium highlights linker-payload and coupling chemistries, ADC development, biomarker and patient selection, and regulatory perspectives.
Wednesday, December 11, 2013 | 12:00 PM - 4:00 PM
Speakers: T. Eric Ballard (Pfizer Worldwide Research and Development), Joseph M. Fox (University of Delaware), Howard C. Hang (The Rockefeller University), Minkui Luo (Memorial Sloan-Kettering Cancer Center), Lisa Shah (SUNY Stony Brook)
Innovations in chemistry often lead to breakthroughs in biology and medicine. This symposium highlights advances in bioorthogonal chemistry, affording opportunities to explore biology and facilitating the synthesis of diagnostics and therapeutics.
Thursday, November 21, 2013 | 8:00 AM - 5:00 PM
Keynote Speaker: Sally Tinkle (IDA/Science and Technology Policy Institute)
Featured Speakers: Yechezkel (Chezy) Barenholz (Hebrew University-Hadassah Medical School), Raj Bawa (Bawa Biotech LLC and Rensselaer Polytechnic Institute), Gerrit Borchard (University of Geneva, University of Lausanne), Ricardo Carvajal (Hyman, Phelps & McNamara, P.C.), Neil Desai (Abraxis Bioscience, A wholly owned subsidiary of Celgene Corporation), Rogério Gaspar (University of Lisbon), Patrick Hunziker (University Hospital Basel), Laurent Levy (Nanobiotix), Scott E. McNeil (Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd. and University of Basel), Ritu Nalubola (US Food and Drug Administration), Lawrence Tamarkin (Cytimmune)
Explore regulatory challenges in the nascent field of nanomedicines including the relevance and adequacy of existing frameworks, availability and expertise of regulators, and safety concerns.
Organizers: Raj Bawa (Bawa Biotech LLC; Rensselaer Polytechnic Institute), Scott E. McNeil
(Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd.; University of Basel, Switzerland), Melanie Brickman Stynes (The New York Academy of Sciences), and Melinda Miller (The New York Academy of Sciences)
Keynote Speaker: Sally Tinkle (Science and Technology Policy Institute, IDA)
This eBriefing explores regulatory challenges in the nascent field of nanomedicines.
Keynote Speakers: KC Huang (Stanford University) and Amir Yacoby (Harvard University)
Panel Moderator: Seth Pinsky (NYC Economic Development Corporation)
This eBriefing documents the 8th condensed matter physics conference featuring keynote talks in hard matter and soft matter as well as a special panel discussion, "Generation Tech: Tapping NYC's Science & Engineering Talent," featuring representatives of the new engineering and applied science institutions that are being created in the city.
Speaker: Caleb Scharf (Columbia University)
This eBriefing documents a presentation by Caleb Scharf, director of astrobiology at Columbia University, who described the latest science on black holes and gave an update on the search for life on other planets.
Keynote Speakers: Leon Balents (University of California, Santa Barbara) and Mohammad F. Islam (Carnegie Mellon University)
At the seventh biannual Gotham-Metro Condensed Matter conference faculty, postdocs, and students shared ideas and research on condensed matter with fellow physicists, covering the spectrum from graphene-based transistors and novel chemical sensors to the fundamentals of colloids, metamaterials, and quantum spin liquids.
Danish biophysicist Ole Mouritsen also happens to be an expert on, and lover of sushi. This week, we talk to him about his new book, Sushi: Food for the Eye, the Body, and the Soul.
December 18, 2009
We sit down with science photographer Felice Frankel and nanotechnology pioneer and Harvard chemist George Whitesides to hear about their new book on nanoscience, No Small Matter.
April 28, 2009
Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.